As mentioned earlier, finding out whether a patient has NASH requires an in-hospital liver biopsy. An NAFLD diagnosis also offers no insights into the etiology of the patient’s disease ...
The limitations of a liver biopsy have led to considerable interest and attempts to diagnose this condition with laboratory tests and imaging modalities. The definitive diagnosis of NAFLD is based ...
Cardiovascular disease (CVD) is the most common cause of death in NAFLD patients. Liver biopsy and noninvasive markers should be used to stage and grade nonalcoholic steatohepatitis (NASH ...
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance and the metabolic syndrome, which are, in turn, associated with obesity. It has been suggested, however ...
“Over time, NAFLD can progress to chronic inflammation ... To enroll in the trial, patients needed to have a liver biopsy showing inflammation due to NASH with moderate or advanced liver scarring.
Understanding the link between Non-Alcoholic Fatty Liver Disease (NAFLD) and cardiovascular disease is essential. Shared risk factors like obesity and diabetes contribute to both. Pharmaceutical ...